Request Trial
7 April 2025NewsCareersMarisa Woutersen

PierFerd taps pharma and biotech patent expert from Weiss & Arons

Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on drug cases involving Lialda, Vyvanse, and Intuniv, among others.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
J&J names two-decade veteran as chief IP counsel
10 September 2026   The senior lawyer previously led Johnson & Johnson’s global pharmaceutical patent team, advising on patent portfolios, R&D, licensing, M&A and litigation.
Careers
UK firm hires head of IP with commercial and technical nous
8 September 2026   With technical specialisms including nucleic acid technologies, biological therapeutics and vaccines, and diagnostics and biological assays, the new hire adds a life sciences patent specialism to the firm’s growing IP practice.
Careers
White & Case life sciences co-leader moves firms
2 September 2026   The senior transactions specialist brings experience advising pharmaceutical, biotechnology and technology companies on strategic alliances, licensing, M&A and cross-border transactions.


Editor's picks

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026

Editor's picks

Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026

More features

J&J names two-decade veteran as chief IP counsel
J&J unit win shuts door on Sandoz generic launch
Abbott clinches 18-country PI in glucose monitoring feud
UK firm hires head of IP with commercial and technical nous
Italy’s Biofer falls short in Fed Circ appeal over key claim wording
G 1/25: EPO settles controversial patent description question
California votes for law to restrict use of genAI by lawyers
Sun Pharma import ban back in force after Squires intervention